搜尋結果
Alzheimer's drug from Eisai and Biogen rejected in Europe
Reuters· 14 小時前, opens new tab Leqembi treatment for early Alzheimer's disease, saying the risk of serious ...
FAA approves SpaceX to resume Falcon 9 rocket launches after two-week hiatus
CNBC· 14 小時前The Federal Aviation Administration has approved SpaceX to resume flights of its mainstay ... ...
Japan nuclear watchdog panel decides against restarting Tsuruga reactor
Reuters· 14 小時前A panel of Japan's nuclear watchdog decided on Friday against restarting a reactor at the ...
Lock maker Assa Abloy resolves US court clash over industry probe
Reuters· 15 小時前Assa Abloy had clashed for weeks in court papers with the corporate monitor supervising its ...
Knockoff Weight-Loss Drug Dosing May Harm Patients, FDA Warns
Bloomberg· 16 小時前Have a confidential tip for our reporters? US health regulators warned that patients may be ...
EU regulator backs use of Novo's Wegovy to lower heart risks
Reuters· 17 小時前The backing from the European Union drug watchdog's committee comes two days after Wegovy ...
Crypto firm Ledger hikes prices of iPod-inspired wallet by 40% and launches new mid-tier option ...
CNBC· 17 小時前The Ledger Flex is a new, cheaper hardware crypto wallet from French startup Ledger. It sports an E-ink display and can ...
Ledger launches Ledger Flex, a mid-range hardware crypto wallet
TechCrunch· 17 小時前Ledger, a French startup mostly known for its secure crypto hardware wallets, has launched a new mid-range device, the Ledger ...
Boeing restarts jet deliveries to China
China Daily· 18 小時前In a busy week for Boeing, the aircraft maker has resumed delivery of 737 MAX aircraft to Chinese airlines ...
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
CNBC· 20 小時前European drug regulators on Friday rejected the Alzheimer's treatment Leqembi from Biogen ...